el-Maghrabi M R, Gidh-Jain M, Austin L R, Pilkis S J
Department of Physiology and Biophysics, State University of New York, Stony Brook 11794.
J Biol Chem. 1993 May 5;268(13):9466-72.
A cDNA encoding human liver fructose-1,6-bisphosphatase was isolated from a lambda gt11 library by screening with a rat liver fructose-1,6-bisphosphatase cDNA. The cDNA (1421 base pairs) contains an open reading frame encoding 337 amino acids, corresponding to a protein with an estimated molecular weight of 36,697. Its primary sequence is highly homologous to that of the pig kidney and rat liver enzymes. The human liver cDNA was used to construct a T7 RNA polymerase-transcribed expression vector, and the enzyme was expressed in Escherichia coli BL21 (DE3). Approximately 50% of the expressed human fructose-1,6-bisphosphatase was soluble and enzymatically active, and the enzyme was purified to homogeneity by heat treatment, ammonium sulfate fractionation, and substrate/AMP elution from carboxymethyl-Sephadex. Expressed human liver fructose-1,6-bisphosphatase had a specific activity (9.8 mumol/min/mg of protein) that was half that of the rat liver enzyme, but had an identical Km for substrate. However, the human enzyme was more sensitive to inhibition by fructose-2,6-bisphosphate (Ki = 0.3 microM) and AMP (Ki = 12 microM) than the rat liver form (fructose 2,6-P2, Ki = 4 microM; AMP, Ki = 40 microM). Crystallographic analyses have suggested that Asp-118 and Asp-121 are catalytic residues located in a negatively charged pocket that binds divalent metal cations. These residues were mutated to alanine, and the E. coli-expressed mutant enzymes were purified to homogeneity. The Asp-118-->Ala and Asp-121-->Ala mutants had 1/5000 and 1/20,000 lower Kcat values than the wild-type enzyme, respectively, consistent with their critical role in fructose-1,6-bisphosphatase catalysis.
通过用大鼠肝脏果糖-1,6-二磷酸酶cDNA进行筛选,从λgt11文库中分离出编码人肝脏果糖-1,6-二磷酸酶的cDNA。该cDNA(1421个碱基对)包含一个编码337个氨基酸的开放阅读框,对应于一种估计分子量为36,697的蛋白质。其一级序列与猪肾和大鼠肝脏酶的序列高度同源。用人肝脏cDNA构建了T7 RNA聚合酶转录的表达载体,并在大肠杆菌BL21(DE3)中表达该酶。大约50%的表达的人果糖-1,6-二磷酸酶是可溶的且具有酶活性,通过热处理、硫酸铵分级分离以及从羧甲基-葡聚糖凝胶上用底物/AMP洗脱,将该酶纯化至同质。表达的人肝脏果糖-1,6-二磷酸酶的比活性(9.8微摩尔/分钟/毫克蛋白质)是大鼠肝脏酶的一半,但对底物的Km相同。然而,人酶比大鼠肝脏形式的酶对果糖-2,6-二磷酸(Ki = 0.3微摩尔)和AMP(Ki = 12微摩尔)的抑制更敏感(果糖2,6-P2,Ki = 4微摩尔;AMP,Ki = 40微摩尔)。晶体学分析表明,Asp-118和Asp-121是位于结合二价金属阳离子的带负电荷口袋中的催化残基。这些残基突变为丙氨酸,并将大肠杆菌表达的突变酶纯化至同质。Asp-118→Ala和Asp-121→Ala突变体的Kcat值分别比野生型酶低1/5000和1/20,000,这与其在果糖-1,6-二磷酸酶催化中的关键作用一致。